Truth or Myth?

FEATUREIs Peer Review Broken?Truth or Myth? © GETTY IMAGESWe presented three common complaints about peer review at top-tier journals to editors at some of those journals. Here are their responses:ARTICLE EXTRASRelated Articles: Is Peer Review Broken?Submissions are up, reviewers are overtaxed, and authors are lodging complaint after complaint about the process at top-tier journal

Written byAlison McCook
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

We presented three common complaints about peer review at top-tier journals to editors at some of those journals. Here are their responses:

Complaint: Editors at commercial journals are young and inexperienced, relative to editors at nonprofit or society journals. As a result, commercial journal editors (such as those at Nature or Cell) often make errors in judgment when sorting through conflicting reviewers' reports, or choose reviewers with obvious conflicts of interest, causing worthy papers to be rejected, or unworthy papers to be accepted.

Responses: It's true that editors at commercial journals are almost always younger than editors at nonprofit or society journals, says Hemai Parthasarathy, managing editor at Public Library of Science (PLoS) Biology. She was once a young editor at Nature and admits that she likely made mistakes in judgment then that she wouldn't make now. However, after 10 years of editing, she notes that editors of any age ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies